Back
Enlivex Therapeutics Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
ENLV
Enlivex Therapeutics Ltd.
Last Price:
$0.74
Seasonality Move:
5.29%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENLV is experiencing slight selling pressure.
Enlivex Therapeutics Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.84 | Sell |
| 20-day SMA: | 0.95 | Sell |
| 50-day SMA: | 1 | Sell |
| 200-day SMA: | 1.07 | Sell |
| 8-day EMA: | 0.85 | Sell |
| 20-day EMA: | 0.91 | Sell |
| 50-day EMA: | 0.88 | Sell |
| 200-day EMA: | 0.45 | Buy |
Enlivex Therapeutics Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 32.89 | Sell |
| Chaikin Money Flow: | -170094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.84 - 1.06) | Sell |
| Bollinger Bands (100): | (0.9 - 1.26) | Sell |
Enlivex Therapeutics Ltd. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enlivex Therapeutics Ltd. Stock
Is Enlivex Therapeutics Ltd. Stock a Buy?
-
Enlivex Therapeutics Ltd. share price is 0.77 while ENLV 8-day simple moving average is 0.84, which is a Sell signal.
-
The stock price of ENLV is 0.77 while Enlivex Therapeutics Ltd. 20-day SMA is 0.95, which makes it a Sell.
-
Enlivex Therapeutics Ltd. 50-day simple moving average is 1.00 while ENLV share price is 0.77, making it a Sell technically.
-
ENLV stock price is 0.77 and Enlivex Therapeutics Ltd. 200-day simple moving average is 1.07, creating a Sell signal.
ENLV Technical Analysis vs Fundamental Analysis
Sell
18
Enlivex Therapeutics Ltd. (ENLV)
is a Sell
Is Enlivex Therapeutics Ltd. a Buy or a Sell?
-
Enlivex Therapeutics Ltd. stock is rated a SellThe current Enlivex Therapeutics Ltd. [ENLV] share price is $0.77. The Score for ENLV is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Enlivex Therapeutics Ltd. Stock Info
Market Cap:
18.8M
Price in USD:
0.77
Share Volume:
864.2K
Enlivex Therapeutics Ltd. 52-Week Range
52-Week High:
2.10
52-Week Low:
0.74
Sell
18
Enlivex Therapeutics Ltd. (ENLV)
is a Sell
Enlivex Therapeutics Ltd. Share Price Forecast
-
What is the Enlivex Therapeutics Ltd. stock price today?The Enlivex Therapeutics Ltd. stock price is 0.77 USD today.
-
Will ENLV stock go up or go down?Enlivex Therapeutics Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is Enlivex Therapeutics Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enlivex Therapeutics Ltd. is overvalued.
Is Enlivex Therapeutics Ltd. Stock a Buy?
-
Enlivex Therapeutics Ltd. share price is 0.77 while ENLV 8-day exponential moving average is 0.85, which is a Sell signal.
-
The stock price of ENLV is 0.77 while Enlivex Therapeutics Ltd. 20-day EMA is 0.91, which makes it a Sell.
-
Enlivex Therapeutics Ltd. 50-day exponential moving average is 0.88 while ENLV share price is 0.77, making it a Sell technically.
-
ENLV stock price is 0.77 and Enlivex Therapeutics Ltd. 200-day simple moving average is 0.45, creating a Buy signal.
Fundamental Analysis of Enlivex Therapeutics Ltd.
Is Enlivex Therapeutics Ltd. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Enlivex Therapeutics Ltd.
Should I short Enlivex Therapeutics Ltd. stock?
-
ENLV Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Enlivex Therapeutics Ltd. is a Sell
-
Enlivex Therapeutics Ltd. Relative Strength Index (RSI) is 32.89, which suggest Enlivex Therapeutics Ltd. is oversold
-
The Bollinger Bands (25) for Enlivex Therapeutics Ltd. is (0.84 - 1.06), which suggest Enlivex Therapeutics Ltd. is a Sell
-
The Bollinger Bands (100) for Enlivex Therapeutics Ltd. is (0.9 - 1.26), which suggest Enlivex Therapeutics Ltd. is a Sell
* Enlivex Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.